Effect of radix clematidis extract on viability of knee osteoarthritis chondrocytes

doi:10.3969/j.issn.2095-4344.2013.02.010

Abstract

Abstract:

BACKGROUND: In recent years, studies have shown that excessive apoptosis of articular chondrocytes is the key factor for the start and progress of osteoarthritis. To study the progress in the use of drugs that inhibit apoptosis of chondrocytes to control osteoarthritis has become a hotspot. Clematis has obtained exact effect in the domestic clinical treatment of osteoarthritis, but the specific mechanism underlying
inhibition of chondrocytes apoptosis has not been reported.
OBJECTIVE: To observe the effect of radix clematidis extract on cell viability of the knee osteoarthritis chondrocytes.
METHODS: Joint cartilage was shredded after harvested from the patients of osteoarthritis undergoing the knee replacements, and chondrocytes were isolated and cultured by the way of enzymatic digestion. The third-passage cells in the logarithmic growth phase were cultured in vitro and randomly divided into six groups after adherence. The experimental groups were cultured in Dulbecco’s modified Eagle’s medium with 0.01, 0.05, 0.1, 0.5, and 1.0 g/L radix clematidis extract, while the control group was given normal medium alone. Live/Dead assay method was adopted to observe the effect of radix clematidis extract with different concentrations on cell viability of the knee osteoarthritis chondrocytes, and TUNEL method was used to assay apoptosis index of the knee osteoarthritis chondrocytes.
RESULTS AND CONCLUSION: 0.05 and 0.1 g/L radix clematidis extracts increased cell viability of chondrocytes, while 0.5 and 1.0 g/L radix clematidis extracts decreased the cell viability of chondrocytes. There was a significant difference in the cell viability between 0.05, 0.1, 0.5, 1.0 g/L radix clematidis extract groups and the control group (P < 0.05). 0.01, 0.05, 0.1 g/L radix clematidis extracts effectively inhibited apoptosis of chondrocytes, while 1.0 g/L radix clematidis extract promote the apoptosis of chondrocytes. There was a significant difference in the apoptotic index between 0.01, 0.05, 0.1, 1.0 g/L radix clematidis extract groups and the control group (P < 0.05). The appropriate concentration of radix clematidis extract could improve chondrocytes viability and restrain chondrocytes apoptosis, and the peak was at 0.1 g/L group. But excessive concentration of radix clematidis extract could reduce chondrocytes viability and promote chondrocytes apoptosis, representing the toxic effects on human articular chondrocytes.

Key words: tissue construction, cartilage tissue construction, clematis, chondrocytes, osteoarthritis, apoptosis, cell viability, apoptosis index, viability index, tissue construction photographs-containing paper

CLC Number:

R318

Xu Yang, Gui Jian-chao, Gao Feng, Xu Yan, Wang Li-ming, Lu Yi-ming, Yin Zhao-wei. Effect of radix clematidis extract on viability of knee osteoarthritis chondrocytes[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(2): 241-246.

Figures/Tables 4

References

[1] Ayache N, Boumediene K, Mathy-Hartert M,et al. Expression of TGF-betas and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondrocytes.Osteoarthritis Cartilage. 2002;10(5):344-352.

[2] Kim HA, Blanco FJ.Cell death and apoptosis in osteoarthritic cartilage.Curr Drug Targets. 2007;8(2):333-345.

[3] Li XL. Guoji Yiyao Weisheng Daobao. 2006;12(23):54-55.李肖斓.中医治疗膝关节骨性关节炎40例临床探讨[J].国际医药卫生导报,2006,12(23):54-55.

[4] Sun YJ,Chen Y,Yu HK. Zhongguo Nongxue Tongbao. 2006; 22(11):86-89.孙玉军,陈彦,余宏凯.威灵仙多糖的提取工艺研究[J].中国农学通报,2006,22(11):86-89.

[5] Enders JT, Otto TJ, Peters HC,et al. A model for studying human articular cartilage integration in vitro. J Biomed Mater Res A. 2010;94(2):509-514.

[6] Zhang Z, McCaffery JM, Spencer RG,et al. Growth and integration of neocartilage with native cartilage in vitro.J Orthop Res. 2005;23(2):433-439.

[7] Thomas CM, Fuller CJ, Whittles CE,et al. Chondrocyte death by apoptosis is associated with the initiation and severity of articular cartilage degradation. Int J Rheum Dis. 2011;14(2): 191-198.

[8] Gao HF,Ren GL,Xu Y,et al. Zhongguo Xiufu Chongjian Waike Zazhi. 2011;25(3):279-284.高航飞,任戈亮,徐燕,等. 在骨性关节炎发病中AQP-1表达量的变化与软骨细胞凋亡的相关性研究[J]. 中国修复重建外科杂志,2011,25(3):279-284.

[9] Sofat N.Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol. 2009; 90(5): 463-479.

[10] Thomas CM, Murray R, Sharif M. Chondrocyte apoptosis determined by caspase-3 expression varies with fibronectin distribution in equine articular cartilage.Int J Rheum Dis. 2011; 14(3):290-297.

[11] Scuderi GJ, Golish SR, Cook FF,et al. Identification of a novel fibronectin-aggrecan complex in the synovial fluid of knees with painful meniscal injury. J Bone Joint Surg Am. 2011;93(4): 336-340.

[12] Weng LH, Wang CJ, Ko JY,et al. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum. 2010;62(5):1393-1402.

[13] Hashimoto S, Setareh M, Ochs RL,et al. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum. 1997;40(10):1749-1755.

[14] Dian LH. Xibei Yaoxue Zazhi. 2004;19(5):231-232.典灵辉.中药材威灵仙的研究进展[J].西北药学杂志,2004,19(5): 231-232.

[15] Zhao YQ,Yang LX. Zhongyaocai. 2008;31(3):465-470.赵燕强,杨立新.威灵仙的成分、药理活性和临床应用的研究进展[J].中药材, 2008,31(3):465-470.

[16] Chen FY,Wang X,Gu XJ,et al. Zhongguo Jiaoxing Waike Zazhi. 2006;14(5):360-363.陈飞雁,王旭,顾湘杰,等.威灵仙注射液对骨关节炎模型动物软骨组织形态和胶原表达的影响[J].中国矫形外科杂志,2006, 14(5): 360-363.

[17] Ma Y,Zhang YS,Xu JA,et al. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2010;14(11):1901-1909.马勇,张允申,许建安,等.威灵仙干预体外培养兔膝关节软骨细胞增殖及转化生长因子β1 mRNA基因的表达[J].中国组织工程研究与临床康复,2010,14(11):1901-1909.

[18] Zhu XX,Zhi YF,Shao SJ,et al. Shiyong Zhongyi Neikexue Zazhi. 2006;20(6):603-604.朱萱萱,支月芳,邱召娟,等.痛痹颗粒及拆方的含药血清对家兔软骨细胞增殖与凋亡的影响[J].实用中医内科学杂志,2006,20(6): 603-604.

[19] Zhang SH,Teng JW,Wang FJ,et al. Jilin Zhongyiyao. 2011; 31(11): 1126-1128.张世华,滕加文,王富军,等.补肾壮骨胶囊对兔膝骨性关节炎软骨细胞凋亡的影响[J].吉林中医药,2011,31(11):1126-1128.